Daily Insider Signal · July 30, 2026

Insider Alert: Catalyst4, Inc. Bought MLPT Shares (95/100 Signal)

Ticker

MLPT

Action

Bought

Shares

1,000,000

Signal Score

95/100

Catalyst4, Inc. bought 1,000,000 shares of MapLight Therapeutics, Inc. (MLPT) at $13.00 for a total transaction value of $13,000,000.

This trade scores 95/100, indicating very high conviction. Large open-market purchases by C-suite executives with minimal noise factors are rare and historically correlated with positive 90-day forward returns.

What to watch: Monitor upcoming earnings dates, any subsequent Form 4 amendments, and cluster activity (multiple insiders buying within a 30-day window). Single-insider signals are most powerful when corroborated by broader insider clustering or supportive technical trends.

What this signal means

DisclosureSignals scores every SEC Form 4 filing on a 0–100 scale. This trade earned a 95/100 signal score by weighing the transaction type, insider role, trade size, cluster buying, the insider's own history, and whether the trade was discretionary rather than part of a scheduled 10b5-1 plan. A higher score indicates a more unusual, conviction-driven purchase. Read the full methodology.

See every recent Form 4 filing for MLPT, including historical insider trades and trend context.

Transaction Details

Insider
Catalyst4, Inc.
Company
MapLight Therapeutics, Inc.
Transaction Date
July 30, 2026
Price Per Share
$13.00
Total Value
$13,000,000
Type
Purchase

Get Real-Time Insider Alerts

DisclosureSignals monitors SEC EDGAR every 15 minutes and scores every Form 4 filing. Don't miss the next high-conviction signal.

View Free Dashboard →